Impact Factor success for open access publisher BioMed Central
24 Jun 2013
BioMed Central’s flagship journal Genome Biology passed a major milestone this week, increasing its Impact Factor to double figures in the Thomson Reuters 2012 Journal Citation Report (JCR). The new Impact Factor of 10.288 confirms its position as the top-ranked journal in BioMed Central's portfolio.
BMC Medicine, also one of BioMed Central's leading titles, increased its Impact Factor to 6.679, moving up to an impressive rank of 7th of 191 titles in the JCR category of General and Internal Medicine.
In all, 21 of BioMed Central and Chemistry Central journals received their first Impact Factors this year, meaning that 146 of the publisher’s 261 journals now have Impact Factors. Of the journals which already had an impact factor, a significant majority increased it in this year's JCR.
Deborah Kahn, BioMed Central’s Publishing Director says: “Though Impact Factors are by no means perfect, they continue to play an important role in helping authors and librarians to evaluate journals, so we are pleased to see the excellent performance of our journals reflected in their JCR rankings.”
Matthew Cockerill, BioMed Central’s Managing Director says: “BioMed Central is committed to making as many metrics as possible available to help researchers make informed decisions. The Impact Factors in the latest JCR are important as confirmation that open access research published in BioMed Central's journals goes on to be highly cited, but they do not tell the full story of the wider impact of that research. We have recently extended our collaboration with altmetric.com to make available a list of 'top trending articles' for each BioMed Central member institution*, based on social media mentions, and continue to add additional sources of metrics at both the article and journal level."
-ENDS-
Media Contact
Rebecca Fairbairn
Public Relations Manager, BioMed Central
Tel: +44 (0) 20 3192 2433
Mob: +44 (0) 7825 257423
Email: rebecca.fairbairn@biomedcentral.com
Notes to Editors
1. A full listing of the latest BioMed Central journal Impact Factors can be found here:
http://www.biomedcentral.com/about/faq/impactfactor
Additional Impact Factor highlights include:
• Particle Fibre and Toxicology increased its Impact Factor to 9.178, placing it 2nd in Toxicology
• Molecular Cancer increased its Impact Factor to 5.134
• Malaria Journal increased its Impact Factor to 3.4, maintaining its rank as 2nd in Tropical Medicine
• Parasites & Vectors increased its Impact Factor to 3.25
• The society journal Journal of Cardiovascular Magnetic Resonance increased its Impact Factor to a new high of 4.44
• Alzheimer's Research & Therapy received a first Impact Factor of 4.39
• EvoDevo received a first Impact Factor of 3.914
For an example, see: http://www.biomedcentral.com/inst/46559/trending
2. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector. @BioMedCentral
